Our understanding of key epigenetic regulators involved in specific biological processes and cancers is still incomplete, despite great progress in genome-wide studies of the epigenome. Here, we carried out a systematic, genomewide analysis of the functional significance of 615 epigenetic proteins in prostate cancer (PrCa) cells. We used the high-content cell-spot microarray technology and siRNA silencing of PrCa cell lines for functional screening of cell proliferation, survival, androgen receptor (AR) expression, histone methylation and acetylation. Our study highlights subsets of epigenetic enzymes influencing different cancer cell phenotypes. Plant homeo domain (PHD) finger proteins have a key role in cell survival and histone methylation, whereas histone deacetylases were primarily involved in regulating AR expression. In contrast, JumonjiC-domain (JmjC) containing histone lysine demethylases (KDMs) mainly had an impact on cell proliferation. Our results show that the KDMs JARID1B, PHF8, KDM3A, KDM3B and KDM4A were highly expressed in clinical PrCa samples. The PHD-finger protein 8 (PHF8), a transcriptional coactivator with both PHD-and JmjC-domains, was moderately to strongly expressed in 80% of clinical PrCa samples, whereas 76% of normal and benign samples were negative or only showed weak PHF8 expression. Strong PHF8 expression correlated significantly with high Gleason grade and was borderline significant for poor prognosis. The results of functional PHF8 knockdown implicate a role in cell migration and invasion, as shown by cell motility and 3-D invasion assays. Our study suggests that various cellular phenotypes are regulated by distinct subsets of epigenetic enzymes. Proteins interpreting and modifying histone methylation, such as JmjC-domain and particularly PHDfinger proteins like PHF8, are activated in subsets of PrCa's and promote cancer relevant phenotypes.
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Introduction
Cancer initiation and progression have been recognized as complex processes that involve both genetic and epigenetic alterations (Sharma et al., 2010) . Epigenetic changes in cancer progenitor cells may represent early or initial steps in tumorigenesis, resulting in polyclonal precursor populations prone to the accumulation of additional genetic and epigenetic defects (Holst et al., 2003) . Furthermore, global changes in histone modification patterns are functionally associated with cancer development and recurrence (Fraga et al., 2005; Seligson et al., 2005 Seligson et al., , 2009 ). These epigenetic modifications are mediated by antagonizing sets of enzymatic complexes: the 'writer' proteins, which attach chromatin modifications in a site-specific manner, and the 'eraser' proteins that remove these (Ruthenburg et al., 2007) . Such modifications are interpreted by 'reader' proteins that specifically bind to the modified chromatin. These complexes direct transcriptional regulator complexes to active promoter sites. Aberrant expression of epigenetic targets, including DNA methyltransferases, methyl-CpG-binding proteins, histone lysine acetyltransferases, histone deacetylases (HDACs), histone lysine methyltransferases, histone lysine demethylases (KDMs) and Polycomb group proteins mediate cancer development and progression (Ellis et al., 2009) . A spectrum of diverse DNA methyltransferase and HDAC inhibitors are currently in clinical development, whereas some have already been approved as anticancer drugs (Egger et al., 2004; Minucci and Pelicci, 2006) , and represent the first examples for a novel concept of therapeutics.
Prostate cancer (PrCa) represents the third most common cause of cancer deaths among Western men, primarily because of the development of castrationresistant metastasizing cancer. Substantial evidence supports the involvement of epigenetic processes in PrCa progression (Seligson et al, 2005) . At the DNA level, multiple tumor suppressor genes involved in regulation of prostate differentiation, proliferation or metastasis are effectively silenced by promoter methylation; frequently detected already in premalignant lesions (Cooper and Foster, 2009) . Furthermore, global chromatin methylation and acetylation studies have revealed histone modification patterns that may be predictive for PrCa recurrence (Ellinger et al., 2010; Bianco-Miotto et al., 2010) . For example, increased global levels of Histone H3 lysine 4 dimethylation and H3K18 acetylation are statistically linked to an increased risk of tumor recurrence (Bianco-Miotto et al., 2010) . In line with this, epigenetic enzymes interpreting and modifying histones are often aberrantly expressed in PrCa (Cooper and Foster, 2009 ), such as class I HDACs, which are overexpressed in aggressive and hormone-refractory PrCa, thus contributing to androgen-independent, lethal PrCa's (Halkidou et al., 2004; Weichert et al., 2008) . Eight KDMs are highly expressed in PrCa's (Metzger et al., 2005; Kahl et al., 2006; Wissmann et al., 2007) . Various HDACs and KDMs were shown to regulate androgen receptor (AR)-mediated transcription, thus affecting gene expression patterns essential for PrCa proliferation, development and progression (Yamane et al., 2006; Wissmann et al., 2007; Wolf et al., 2007; Xiang et al., 2007; Welsbie et al., 2009) . Despite the emerging role of epigenetic processes and large scale mapping of cancer-associated chromatin modifications in PrCa, the functional significance of key 'readers', 'writers' and 'erasers' has not been systematically evaluated. In the present study, we have systematically screened the functional role of 615 epigenetic genes representing all known and putative epigenetically active players in the human genome by siRNA knockdown. Our multiplexed cell-based screens addressed proliferation, apoptosis, expression of AR, and global histone methylation and acetylation in PrCa cells. In these functional screens, we identified the family of JmjC-domain containing histone demethylases as critical for PrCa proliferation and survival. These 32 histone demethylases and primarily JmjC-domain containing proteins were then further evaluated by a second, focussed knockdown screen across a panel of normal and malignant prostate and PrCa cell lines. We identified PHF8 to be highly expressed in PrCa and involved in cell proliferation and motility, which was further validated by a series of cell biological followup studies.
Results
HDACs and JmjC-domain KDMs regulate PrCa cell proliferation and AR protein levels In order to cover the complete repertoire of epigenetic enzymes in the human genome, we have created an epigenetic siRNA library, targeting genes with Gene Ontology (GO) annotations related to epigenetics, chromatin remodelling/maintenance, and co-regulatory functions. We included genes that contained at least one key epigenetic protein domain (for example, SET, bromo, JmjC, plant homeo domain (PHD), HDAC or chromo). Additional candidates were selected based on literature meta-searches and protein-protein-interaction data of epigenetic transcriptional regulator complexes. This concerted approach defined a set of 615 human genes with known or assumed epigenetic activity (Figure 1a , Supplementary Table 1 ). In combination with a selection of controls, each gene was targeted by two independent siRNAs, resulting in a library of 1328 siRNAs. This library was spotted on plastic cell culture carriers and screened by the cell-spot microarray technique (Rantala et al., 2010; Rantala et al, 2011) in VCaP cells. The impact of silencing on PrCa growth (Ki67), survival (cPARP) and expression of AR were addressed by high-content immunofluorescence staining and imaging, using specific antibodies ( Figure 1b) . Additionally, altered global levels of H3K4 and H3K9 dimethylation and H3K18 and H4K16 acetylation, linked to poor cancer prognosis, were studied (Fraga et al., 2005; Seligson et al., 2009) (Figure 1b) . The functional effects of siRNAs was considered significant if the difference of staining intensity exceeded a Z-score 4 þ 2 s.d., compared with the median of scrambled control siRNAs. This resulted in the identification of 272 siRNAs, targeting 231 genes affecting the various endpoints (Supplementary Figure S1) . GO enrichment analysis of primary hits was used to select significantly over-represented protein families for secondary screening (DAVID; http://david.abcc.ncifcrf.gov/).
Clustering of cell-spot microarray screening data by portioning around medoids (PAM) Our large-scale primary screen was primarily designed to identify epigenetic gene classes that significantly affect PrCa cell survival, proliferation, AR expression and histone modifications, but at this stage not focused on identification of single candidate genes. Therefore, the Z-scores of hit siRNAs from all the seven immune staining markers were grouped into six clusters using portioning around medoids and hierarchical clustering (Figure 1c ). To identify significantly enriched protein domains, we functionally annotated each of the clusters separately against the InterPro protein domain database (http://www.ebi.ac.uk/interpro/) and EASE score (Hosack et al., 2003) , Supplementary Table 2, filtering against the 615 input genes as background. This approach revealed that some of the PHD-finger domain-containing proteins were significantly enriched in the cluster of siRNAs that reduce cell survival, and increase global H3K4 dimethylation (Figure 1c , Cluster I). As expected, the cluster of siRNAs reducing global H3K18 acetylation and H4K16ac levels contained most proteins with HDAC domains (Figure 1c , Cluster 2). Interestingly, siRNA hits that strongly affected AR expression and Ki67, were clustered in the same group. Another set of siRNAs targeting mainly JmjC-domain containing proteins significantly reduced cell proliferation and simultaneously upregulated global H3K9 dimethy-lation ( Figure 1c, Cluster 3) . A large group of siRNAs targeting high mobility group (Lange et al., 2008; Tang et al., 2010) and a second set of PHD-finger proteins induced cell proliferation, upregulated AR, and increased global levels of H3K4 dimethylation and H3K18 and H4K16 acetylation (Cluster 6, Supplementary Figure 1 ). Our primary screen thus indicated that the most promising classes of epigenetic enzyme for PrCa therapy may be represented by HDACs (Bjorkman et al, 2008) and JmjC-domain KDMs, as silencing of both protein classes significantly reduced AR expression and cell proliferation.
Systematic analysis of all 32 histone demethylases-and JmjC-domain-containing proteins identifies three histone demethylases important for PrCa cell proliferation Next, we selected all 32 genes containing histone demethylase activity (for example LSD1) or contained Supplementary Figure 1) . Different end point measurements were grouped by hierarchical clustering and included Histone H3 lysine 9 dimethylation (H3K9me2), cleaved poly(ADP-ribose) polymerase (cPARP), Histone H3 lysine 4 dimethylation (H3K4me 2 ), cell proliferation (Ki67), Histone H3 lysine 18 acetylation (H3K18ac), AR and Histone H4 lysine 16 acetylation (H4K16ac). Red denotes an increase in the Z-score reflecting the protein staining intensities whereas blue represents a reduction. Table 4 ). Concurrently, we explored mRNA expression of all 32 histone demethylases in a set of 149 normal prostate and 349 prostate adenocarcinoma samples, based on the GeneSapiens database (Kilpinen et al., 2008 , http://www.genesapiens.org/). Five histone demethylases (KDM3A, KDM3B, KDM4A, JARID1B and PHF8) were identified as significantly (Po0.05) overexpressed in PrCa versus normal prostate. Of these, specific silencing of PHF8 also significantly reduced cell proliferation in the secondary screens (Table 1) .
PHF8 is overexpressed in PrCa and reduces PrCa cell proliferation
The genes JARID1B and KDM4A were described before as highly expressed in PrCa, and function as coactivators of AR (Shin and Janknecht, 2007; Xiang et al., 2007) . In contrast, PHF8 mRNA was not previously described as significantly (Po0.0001) overexpressed in PrCa versus normal prostate. We therefore conducted a large-scale meta-analysis monitoring altered PHF8 mRNA gene expression across selected, large-scale and publicly available gene expression studies, for example, the expression analysis in Oncology project (Figure 2a ), the recent comprehensive clinical PrCa profiles from MSKCC (Taylor et al., 2010; Figure 2b) , and an older study (Chandran et al., 2007, Figure 2c ). Furthermore, we studied PHF8 expression in our GeneSapiens database (Kilpinen et al., 2008) across 496 PrCa samples ( Figure 2d ). In all analyzes, PHF8 was significantly overexpressed in PrCa compared with normal/benign samples. Next, we studied PHF8 protein expression using immune-histochemical staining in tissue microarrays (TMAs) containing a total of 1179 cores, corresponding to 332 cancer and 90 normal/benign specimens. Although 76% of normal/benign samples were negative or showed only weak PHF8 expression, 80.3% of PrCa cases showed moderate to strong expression (Figures 3a and b) . Increased PHF8 expression significantly correlated with high Gleason grades ( Figure 3c , Pearson w 2 ¼ 0.03, Spearman correlation þ 0.023) and was borderline significant in Kaplan-Meier survival analysis ( Figure 3d ; P ¼ 0.06211). Interestingly, no adverse events were observed in 273 PrCa's with low/negative PHF8 expression, whereas the PHF8-high patients had an overall 81% survival (240 months). PHF8 protein was located in the nucleoli, in accordance with previous studies in vitro (Feng et al., 2010; Zhu et al., 2010) . 
PHF8 regulates motility-related gene expression patterns in PrCa
To explore the functional consequences of high PHF8 expression in vivo cancer context, we studied PHF8 co-expressed genes in 233 prostate tumor samples using the GeneSapiens transcriptomics database (Kilpinen et al., 2008) . In all, 757 genes correlated significantly (correlation X0.7, Po0.0001, FDR 0%) with PHF8 in prostate tumors (Supplementary Table 5 ). Functional GO annotation analyses (Hosack et al., 2003) revealed enrichment of genes linked to the central nervous system development and regulation of the actin cytoskeleton, as well as axon guidance and regulation of the actin cytoskeleton, both processes closely linked to cell motility (Supplementary Table 6 ). This was further validated by the identification of genes functionally linked to cellular motility processes like integrins ITGB2, ITGAM, ITGA9, ITGAB2, fibronectin, RhoQ and ROCK kinase 1. To experimentally verify this finding, we studied altered gene expression in LNCaP cells as the result of PHF8 silencing. PHF8 silencing significantly reduced the expression of PHF8 mRNA after 48 h posttransfection, as shown by quantitative RT-PCR (Figure 4a ) and western blot (Figure 4b) . A small set of 62 genes was significantly downregulated and 22 genes were upregulated by PHF8 knockdown (fold change ± 1.4, Po0.05) (Volcano plot; Figure 4c , The mRNA expression of 32 histone demethylases in 149 normal and 349 prostate adenocarcinoma samples was compared in our GeneSapiens human transcriptomics database and the significance of the overexpression was calculated with t-statistics.
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Supplementary Table 7 ). The observed ratio of few upregulated to many downregulated genes was in line with the suggested positive coactivator function of PHF8 (Fortschegger et al., 2010) . Functional annotation of the 62 downregulated genes showed significant enrichment of the integrin signaling pathway. This correlates with our in silico findings, which linked PHF8 to gene expression patterns related to cell motility (Supplementary Table 6 ). Functional knockdown of PHF8 also had significant, but not dramatic effects on apoptosis in LNCaP cells (Figure 4d ).
PHF8 mediates cancer cell migration and invasion
As modulation of the actin cytoskeleton and integrin signaling are linked to cellular movement (Guo and Giancotti, 2004) , we hypothesized that PHF8 may have a role in PrCa cell migration and invasion. Cell migration and invasiveness was studied in PC-3 cells, PHF8 mediates cell migration in prostate cancer M Björkman et al because these were the most motile/invasive cells in both 2-D monolayer and 3-D organotypic cultures (Harma et al., 2010) . PC-3 cells expressed similar levels of PHF8 as LNCaP, which are considerably less invasive in 3-D. PHF8 was thus silenced by siRNA and in parallel overexpressed, using an HA-tagged expression vector that contains the PHF8 open reading frame under the control of the CMV promoter. Cumulative cell movement and motion paths were tracked for a period of 16 h with a phase contrast microscope. PHF8 overexpression of PHF8 significantly increased (Po0.001) the median length of the migration path (Figure 5a ). Concordantly, silencing significantly decreased the median length of the cell migration path (Po0.001) (Figure 5b ). These data suggests that PHF8 supports the regulation of cell migration and motility, possibly via its effects on expression of genes like integrins, ROCK kinase and others (Supplementary Table 6 ). In contrast, in scratch wound/wound healing cell migration assays, PHF8 knockdown showed only minor effects on cellular motility (Supplementary Figure 4) .
Additionally, the role of PHF8 in cell invasion was studied using 3-D organotypic cell culture models (Harma et al., 2010) . This method allows monitoring the effect of gene silencing on morphology, polarization and growth of PrCa spheroids, which typically corresponds to the remaining differentiation potential of cancer cells. 3-D assays also allow the simultaneous measuring of both cell growth ( ¼ spheroid size) and invasion ( ¼ formation of invadopodia, degradation of basement membrane, loss of rounded spheroid shape and overt migration of cells into the extracellular matrix). PHF8 expression was silenced by RNAi for 68 h; the cells were then transferred into Matrigel and imaged for 8 days. Phase contrast images (Supplementary Figure 3) were analyzed with VTT's proprietary automated image analysis program ACCA developed for dynamic morphometric measurements in multicellular spheroids. PC-3 spheroids first form invasive filopodia (invadopodia) 6 days after seeding (Figure 5c ). PHF8 silencing significantly (Po0.0001) reduced both the spheroid size ('area') and the number of invasive 
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M Björkman et al cellular structures ('appendages'), and the spheroids remained in a round shape (% roundness; Figure 5d ). In contrast, spheroids transfected with the scrambled control siRNA (left) and the poorly effective siPHF8_2 lose the round shape and form invadopodia and invasive structures. Furthermore, the most effective siPHF8_1 also significantly increases the number of apoptotic cells inside the spheroids. These data demonstrate that PHF8 regulates proliferation and invasive phenotypes not only in classical 2-D cell culture models, but also more prominently in 3-D organotypic PrCa cell models.
PHF8 mediates prostate cell proliferation
As PHF8 has been previously linked to rRNA synthesis and assigned a putative function in cell cycle progression (Feng et al., 2010; Liu et al., 2010; Zhu et al., 2010) , we set out to validate these effects in PrCa cell lines. PHF8 silencing significantly (Po0.001) reduced cell proliferation of the most rapidly proliferating PrCa cell lines (LNCaP, 22rV-1, DU-145 and PC-3), and least affected the nontransformed normal primary prostate epithelial and premalignant RWPE-1 cells ( Figure 6 ). We further analyzed the effects of PHF8 silencing on cell cycle progression, using propidium-iodine staining and FACS analysis (Figure 6b ), which showed only minor but statistically significant changes in (Po0.01) of LNCaP cells in the G1 phase after PHF8 silencing. The most striking differences are revealed in long-term growth analyses using the IncuCyte real-time imaging device (Essen Bioscience, Ann Arbor, MI, USA) (Figure 6c ).
Discussion
Our systematic high-content functional screen covered most known epigenetic enzymes and regulators with several functional phenotypic endpoints, and resulted in the identification of distinct classes of epigenetic modifiers as critical for cancer biology. The use of multiple endpoint measurements indicated overall protein-domain specific effects, and pointed to a prominent role of, for example, PHD fingers in cell survival and H3K4 dimethylation. In contrast, HDACs were primarily functional in the regulation of the AR expression, whereas JmjC-domain KDMs mainly regulated cell proliferation. Overall, this analysis demonstrates the distinctive value of genome-wide, systematic functional knockdown screens, addressing all known epigenetic enzymes in parallel. These studies have the potential to identify the most potent regulators as well as highlight their functional importance not only as single genes but also as distinct groups. Silencing of a specific set of PHD-finger genes in PrCa cells increased both global levels of H3K4 dimethylation and apoptosis. Over 200 PHD-finger proteins exist in the human genome, which interact specifically with trimethylated histone H3K4 and K36, thus interpreting and mediating methylation events into epigenetic programs (Mellor et al., 2006; Shi et al., 2007) . Aberrant expression of several PHD-finger proteins is associated with a wide range of human pathologies, including cancers and neurological diseases (Baker et al., 2008) . Histone H3K4 di-and trimethyla- tion sites are enriched at actively transcribed promoter and enhancer chromatin regions (Ernst and Kellis, 2010) , and regulate gene expression particularly in development (Ruthenburg et al., 2007) . Our screen suggests that PHD-finger proteins may also be involved in the observed global loss of Histone H3K4 dimethylation, associated with tumor recurrence in PrCa patients (Seligson et al., 2005) . Our study also identified HDACs as the main epigenetic protein class resulting in reduced AR protein levels upon silencing. This is in line with previous observations, indicating that HDAC inhibitors potently reduce AR protein expression, and downregulate androgen-responsive genes (Bjorkman et al., 2008; Welsbie et al., 2009) . Overall, these data suggest that HDACs have a specific role in regulating AR activity and AR signaling in castration-resistant PrCa. Thus, HDAC inhibitors could become an important therapeutic option for advanced PrCa patients in the future.
Furthermore, we identified the JmjC-domain containing protein family as critical for PrCa cell proliferation. JmjC proteins were enriched among those siRNAs that significantly reduced Ki67 staining. We further validated these results by a secondary screening, targeting 32 KDMs and JmjC-domain containing proteins in a panel of PrCa cell lines and non-transformed normal epithelial cells. This experimental approach was combined with an in silico analysis of JmjC protein expression across several large-scale clinical transcriptome data sets, linking for the first time the histone demethylase PHF8 with progression of PrCa. PHF8 was previously identified to demethylate mono-and dimethylated histone H3K9 and monomethylated histone H3K20 (Horton et al., 2010; Loenarz et al., 2010; Qi et al., 2010) . Inactivating mutations in the PHF8 JmjCdomain are linked to mental retardation syndromes with the cleft lip/palate (Laumonnier et al., 2005; Abidi et al., 2007; Koivisto et al., 2007; Qiao et al., 2008) . This may be because of critical transcriptional co-activator functions of PHF8 in the regulation of neuronal and craniofacial development (Fortschegger et al., 2010; Kleine-Kohlbrecher et al., 2010; Qi et al., 2010) . Furthermore, we showed that PHF8 mRNA is overexpressed in a large fraction of PrCa and correlated with features of tumor progression such as high Gleason grading. This correlation with adverse events and poor patient survival was further validated by immunohistochemistry staining of TMAs from clinical samples. Immunohistochemical staining of PrCa tissues showed that PHF8 localization was preferentially nucleolar, compatible with the assumed function of an epigenetic modifier and the previously reported role in regulation of ribosomal RNA promoters (Feng et al., 2010) . Enhanced activity of ribosomal gene expression is a typical observation in hyper-proliferative cancers.
Both the analysis of putative PHF8-regulated genes in the LNCaP cell line, and the genes correlating with PHF8 expression in primary PrCa showed an enrichment of GO categories related to the actin cytoskeleton and integrin signaling. Time-lapse microscopy and 3-D organotypic cell cultures showed that PHF8 is also a strong mediator of cancer cell migration and invasion (Figure 4) , and has weak anti-apoptotic functions. A more detailed analysis of potential PHF8 target genes involved in PrCa cell migration may be an important area for future investigation, and to elucidate the functional mechanisms PHF8 is involved in. Interestingly, PHF8 was found to bind to the integrin beta-1 promoter, and linked to positive regulation of genes related to focal adhesion in HeLa cells (Fortschegger et al., 2010) . PHF8 silencing also reduced proliferation and mildly inhibited G1-S phase transition, which is in line with a suggested role of PHF8 in cell cycle progression (Feng et al., 2010; Liu et al., 2010) . However, a functional role of PHF8 in cancer metastasis and invasion needs to be further verified in relevant in vivo models.
Taken together, our findings suggest again that effector proteins like PHF8, which are involved in interpreting and modifying histone methylation marks, may have a significant role in PrCa pathogenesis and progression. Several epigenetic cancer therapies targeting histone acetylation and DNA methylation have been established in the clinics, and the enzymes or protein complexes involved in modifying histone methylation are considered to be highly attractive drug targets. KDMs can be non-specifically targeted by amine oxidases inhibitors, which are currently indicated as antidepressants (Lee et al., 2006) . Recent reports showed that PrCa cell lines respond to MAOA inhibitors, possibly via inhibition of KDM's (Flamand et al., 2010) . Furthermore, the JmjC-domain containing KDMs including PHF8 were found to be repressed by compounds targeting the Fe (II)/a-ketoglutarate dependent oxygenases (Cloos et al., 2006; Smith et al., 2007; Rose et al., 2008) . Taken together, such compounds and epigenetic therapeutic concepts may offer intriguing starting points for the development of novel epigenetic therapies for PrCa. These may be particularly attractive in subsets of tumors that show overexpression of the respective protein targets and pathways, such as PHF8 nuclear overexpression. Larger scale efforts of mapping epigenomic landscapes in cancer (Abbott, 2010) , combined with the functional understanding of the function of epigenetic enzymes, may help to identify the most feasible and cancer-specific epigenetic therapy formats in the future.
Materials and methods

Cell lines
The prostate cell lines RWPE-1, MDA PCa 2b, DU-145 LNCaP and PC-3 were purchased from ATCC (LGC Promochem AB, Boras, Sweden), and grown in the media recommended by the distributor. The prostate carcinoma cell line VCaP was received from Adrie van Bokhoven (University Medical Center Nijmegen, Netherlands). All tumor cell lines were grown in the RPMI-1640 medium. All media were supplemented with 1% (for RWPE1, prostate epithelial cells) or 10% FCS (all cancer lines), L-glutamine and penicillin/streptomycin (all reagents from Sigma, Munich, Germany). All cells were cultured for o4 months before use in these experiments.
Cell-spot microarrays
Cell microarray screens were performed, normalized and analyzed as previously described in (Rantala et al., 2010 and Rantala et al., 2011) . Briefly, the epigenomic siRNA library (Qiagen, Hilden, Germany) was complexed with lipid transfection agents and Matrigel (BD Biosciences, San Jose, CA, USA) and spotted/arrayed onto an untreated hydrophobic polystyrene surface. VCaP cells were applied onto the array as a suspension, and allowed to adhere for 15 min. Unattached cells were then washed off. After 48 h cells were fixed with 2% paraformaldehyde and permeabilized with 0.3% Triton-X 100 and 10% horse serum in PBS, and blocked with 10% horse serum. Arrays were assayed with antibodies for Ki-67 (Abcam, Cambridge, UK), cleaved PARP (Cell Signalling Technologies, Danvers, MA, USA), AR (Thermo Scientific, Waltham, MA, USA), histone H3 lysine 4 dimethylation (Abcam) and H3K9me2 (Abcam), and labeled with goat-anti-mouse and donkey-anti rabbit Alexa488, À555 or À647 dyes (Molecular Probes, Carlsbad, CA, USA). Immunostained cell microarrays were analyzed by microscopic imaging, using an Olympus scanR high content imager (Olympus, Hamburg, Germany) equipped with a Hamamatsu ORCA-ER CCD digital camera (Hamamatsu Photonics K.K., Hamamatsu, Japan). Spot images were analyzed using the scanR image analysis software (scanR Inc., Palo Alto, CA, USA). Total raw mean intensities of stains for all cells per spot were normalized using pin normalization. For analysis of significance, a Z-score was calculated for all measured parameters of each spot using global array mean value and s.d. for all samples in the array, including controls. From this analysis, siRNAs with Z-scores ± 2 s.d. were considered significant. To assay all seven biological endpoints, four independent replicate arrays with dual staining of the markers were used. siRNA protein class-based pattern identification analysis For analysis of significance, a Z-score was calculated for all measured parameters of each array spot using global array median value and s.d. for all samples in the array, including the controls. From the analysis, siRNAs with Z-scores ± 2 s.d. greater or less than the global array median were considered significant. The partitioning around medoids method as implemented in the R package cluster was used for dividing the siRNAs exceeding the threshold in any of the seven markers into six clusters. The R statistical programming language was employed for hierarchical clustering within the clusters. The DAVID online GO-mining tool and the EASE score (Hosack et al., 2003) were employed to identify Interpro domains and protein families enriched in clusters with cancerrelevant properties (Supplementary Table 2 ). The siRNAs included in the secondary screening were selected based on the enrichment analysis results.
siRNA and DNA transfections SiRNA molecules targeting the gene of interest were transfected by using reverse transfection with siLentFect transfection reagent (Bio-Rad Laboratories, Hercules, CA, USA) in Opti-MEM (Invitrogen, Carlsbad, CA, USA). All target genes and siRNAs used are listed in Supplementary Tables 1 and 3 . AllStars Negative Control (Qiagen) was used as scrambled control. The final siRNA concentration used was 13 nmol/l. HA-tagged PHF8 expression vector was a generous gift from Professor Kristian Helin (Biotech Research and Innovation Centre, University of Copenhagen, Denmark). 1 mg of DNA was transfected into RWPE1 and PC-3 cells grown at 70% confluency, using the FuGeneHD transfection reagent (Applied Biosciences, Basel, Switzerland), according to the manufacturer's instruction. The results were compared with mock transfected cells (empty vector).
Statistical analysis of the histone demethylase siRNA screening The secondary screening focused on histone demethylases and JmjC-domain containing proteins, identified as significantly enriched in the primary screen. Four siRNAs per gene were used. To normalize the siRNA screening data the loess function from the R-package 'stats', using row and column coordinates as predictors, was fitted across each 384-well plate. In order to achieve a robust fit, statistical outliers were estimated before the fitting was carried out and their weight was set to 10% of the normal weight. The fit was then subtracted from the original values, the data were divided by the median of negative controls on the plate, and log2 transformed. All siRNAs reducing cell viability by at least 1.8 s.d. from the median of the controls (corresponding to Po0.05) were considered as anti-proliferative hits (Supplementary Table 4 ). Each screen was analyzed using the redundant siRNA analysis algorithm and P-values were assigned to each gene. The redundant siRNA analysis P-value represents the likelihood of the corresponding siRNA signal distribution to be generated by chance. Hits confirmed by the redundant siRNA analysis method at level of Po0.05 were used in validation experiments.
Immunoblotting Aliquots of total cell lysates were fractionated on SDS polyacrylamide gels and transferred to Whatman Protran nitrocellulose membranes (Schleicher & Schuell, Whatman Inc., Florham Park, NJ, USA). Membranes were probed with a specific antibody for PHF8 (Abcam ab35471) and equal loading was confirmed with human b-actin (Sigma-Aldrich). Signal was detected with Alexa Fluor-680 goat anti-rabbit and Alexa Fluor-680 conjugated rabbit anti-goat secondary antibodies (Invitrogen Molecular Probes), and scanned with an Odyssey infrared scanner (Li-Cor Biosciences, Lincoln, NE, USA).
Quantitative RT-PCR Total cellular RNA was isolated with the RNeasy kit (Qiagen). For cDNA synthesis, 200 ng of total RNA was reverse transcribed with a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Foster City, CA, USA). Thereafter, the cDNAs were diluted 1/10 and Taqman quantitative real-time-PCR analysis was carried out with an Applied Biosystems 7900HT instrument using specific primers for PHF8 and b-actin designed by the Universal Probe Library Assay Design Center (Roche, Basel, Switzerland). The sequences were as follows: PHF8 forward 5 0 -GCCTCTATTG AGACAGGTTTGG-3 0 , PHF8 reverse 5 0 -TCTTTTGGGCCT TCTGTAGC-3 0 , b-actin forward 5 0 -CCAACCGCGAGAAG ATGA-3 0 and b-actin reverse 5 0 -CCAGAGGCGTACAGGG ATAG-3 0 . The fluorescent Taqman probes were obtained from Roche Human Probe Library (no 3 for PHF8 and no 64 for bactin). The results were analyzed with SDS 2.3 and RQ manager software (Applied Biosystems), and the expression of PHF8 mRNA was determined by the relative quantitation method using b-actin as an endogenous control. Data were collected from two separate biological experiments, which were both run twice with triplicates.
Gene expression analysis with Illumina bead-arrays
Early passage LNCaP cells transfected with scramble and PHF8 siRNAs for 48 h and total RNA was extracted using PHF8 mediates cell migration in prostate cancer M Björkman et al RNeasy Mini kit (Qiagen). Integrity of the RNA before hybridization was monitored using a Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA). Purified total RNA (500 ng) was amplified with the TotalPrep Kit (Ambion, Austin, TX, USA) and the biotin labeled cRNA was hybridized to Sentrix HumanRef-8 Expression BeadChips (Illumina, San Diego, CA, USA). The arrays were scanned with the BeadArray Reader (Illumina). The raw data were quantile-normalized and analyzed with the R/Bioconductor software and beadarray package (Dunning et al., 2007) . Differentially expressed genes from two independent microarray hybridizations were defined to be X1.4-fold under-or overexpressed with a P-value o0.01 (Supplementary Table 7 ). The functional GO and pathway annotations were analyzed for sets of differentially expressed genes by EASE score (http:// niaid.abcc.ncifcrf.gov) (Hosack et al., 2003) .
Cell proliferation assays
Cell proliferation assays were performed on 384-well plates with optimized cell density, plated in their respective growth media. SiRNA and lipid mixture were incubated on the plates 1 h at RT, then cells were added and incubated for 72 h. Cell viability was measured by CellTiter-Glow (Promega, Madison, WI, USA), according to the manufacturer's instructions. The Envision Multilabel Plate Reader (Perkin-Elmer, MA, USA) was used for luminescent signal quantification. The mean values of at least three independent measurements were used and Student's t-test applied for calculating the significance of changes.
Cell cycle analysis
Cell cycle analysis was carried out for scramble and siPHF8 transfected LNCaP cells. Cells were stained with propidium iodine staining after 72 h incubations followed by flow cytometry analysis using the BD FACSArray Bioanalyzer (Becton & Dickinson, Franklin Lakes, NJ, USA). Samples were collected, stained and analyzed according to the manufacturer's instructions. Growth curves in the IncuCute real-time imaging device were generated as described (Harma et al., 2010) .
mRNA expression in clinical samples
Analysis of relative expression level of candidate genes in the GeneSapiens database was performed as described previously (Kilpinen et al., 2008 ). Briefly; relative expression level of candidate genes across 496 clinical human prostate tissue samples, consisting of 147 normal samples and 349 tumors and metastases was analyzed and the statistical significance of the difference in gene expression between these sample groups and correlation of PHF8 expression with other genes was confirmed with t-statistics (Supplementary Tables 5 and 6 ). Other data sets were downloaded from gene expression omnibus or the MSKCC server, normalized and mined using the same online tools (R bioconductor) as described (Kilpinen et al., 2008) .
Clinical PrCa samples
In all, 378 PrCa patients treated with total prostatectomy between the years 1982 and 1998 at the Helsinki University Central Hospital, Finland, were included in this study. Median age of the patients at diagnosis was 63 (44-83) years. None of the patients had received adjuvant therapy before or immediately after the surgery. Histopathological features were reviewed using the corresponding haematoxylin and eosin or herovici-stained slides by two experienced pathologists, and clinical followup information was collected from patient files. All tissue samples were acquired and used according to contemporary regulatory guidelines.
Tissue microarray construction and immunohistochemistry TMA2 blocks were constructed using archival formalin-fixed paraffin-embedded prostatectomy blocks. Recipient blocks were pre-drilled with an automated TMA instrument (TMA Master, 3D Histech, Budapest, Hungary) and donor block cores (+ 1.0 mm) were manually punched (Tissue-Tek Quick-RayTM, Sakura Finetekk Europe B.V., Alphen aan den Rijn, The Netherlands). To account for tumor heterogeneity, at least two cores were drilled from the area containing the most dominant Gleason grade pattern and one core from the area containing the second most dominant Gleason pattern. In addition, one core of each patient contained an adjacent benign glandular area. All cancer cores in the TMA were graded individually, according to contemporary Gleason grading criteria. The TMA blocks contained a total of 1478 cores. Freshly cut TMA sections were mounted on electrically charged glass slides (SuperFrost Plus, Menzel Glaeser, Braunschweig, Germany) and stained with a fully automated immunohistochemical system Benchmark XT (Ventana Medical Systems, Illkirch, France), using a biotin-free multimer-based detection system (ultraView Universal Red, Ventana Medical Systems). The slides were pre-treated with standard cell conditioning, using CC1 buffer and incubated for 60 min with the rabbit polyclonal antibody to PHF8 (1:250, Abcam). Hematoxylin II and Blueing Reagent (Ventana Medical Systems) were used as counterstains. Negative controls were performed by replacing the primary antibody with corresponding rabbit IgG. The TMA slides were digitized with an automated whole slide scanner (Mirax Scan, Zeiss, Go¨ttingen, Germany), using a 20Â objective (numerical aperture 0.75) and a Sony DFW-X710 camera with a 1024 Â 768 pixel CCD sensor (Sony Corporation, Tokyo, Japan). The images were compressed to a wavelet file format (Enhanced Compressed Wavelet (ECW), ER Mapper, Erdas Inc, Atlanta, GA, USA) with a conservative compression ratio of 1:5. The compressed virtual slides were uploaded to a web server (http://fimm.webmicroscope.net) running image server software (Image Web Server, ERDAS Intergraph Inc., Madison, AL, USA). Reliable Gleason grading was possible for 1179 of the 1478 TMA cores stained with PHF8 antibody, and patient overall survival data was available for 332 patients. In the survival analysis, a maximum score of each cancer cores of an individual patient was correlated with the clinical end point. Expression of PHF8 was evaluated by two pathologists (TM/AS) independently from the digitized slides described above. The investigators were blinded to the clinicopathological data at the time of scoring. Nuclear/nucleolar staining intensity was scored as follows: no staining (negative), weak ( þ ), moderate ( þ þ ) or strong ( þ þ þ ) staining.
Cell migration
Cell migration was measured with time-lapse microscopy as previously described (Tuomi et al., 2009) . Briefly, PC-3 cells were transfected for 48 h with either mock, HA-PHF8, scramble or PHF8 siRNA, and cell migration was imaged from eight random fields per treatment for 16 h. Phase contrast images were taken with a Zeiss inverted wide-field microscope (EL Plan-Neofluar 20 Â /0.5 NA objective, 12 frames per hour), equipped with a heated chamber (37 1C) and CO 2 controller (4.8%). Image processing was performed with MetaMorph Offline software (Molecular Devices, Sunnyvale, CA, USA). Length of the migration of 15 to 20 cells per treatment was quantified in pixels.
3-D invasion assays
PC-3 cells were reverse-transfected for 68 h using SiLentFect lipid transfection reagent (Bio-Rad Laboratories, Hercules, CA, USA). Transfected cells were embedded between two layers of Matrigel on Angiogenesis slides (ibidi GmbH) (1500 cellsper well) as described before in Harma et al. (2010) and cultured for 8 days. On day 8, the multicellular structures were visualized with SYTO62 DNA dye (Invitrogen) and NucView 488 caspase detection reagent (Biotium Inc., Hayward, CA, USA). 3-D image stacks were acquired with a Zeiss spinning disk confocal microscope as described in Harma et al. (2010) . Maximum intensity projections were generated and normalized with Slidebook 5.0 software (Intelligent Imaging Innovations (3i) Inc., Denver, CO, USA). Remaining background noise was removed with ImageJ (National Institute of Health, Bethesda, MD, USA). Image projections were then analyzed with VTT's proprietary automated image analysis program software (v1.95). Automated image analysis program segments individual cell structures based on morphological criteria, and assigns numerical values for selected morphological features including area (size), roundness (shape) and roughness (contour). VTT automated image analysis program is specifically designed to measure the number and length of invasive cellular structures (median, index and maximum extension of 'appendages'). Apoptosis is indicated as ratio of NucView signal to structure size. Raw numerical data were further statistically processed and visualized with R/Bioconductor.
